Summary. The aim of the present work was to study the effects of experimental changes in plasma free fatty acid (FFA) levels on basal insulin (I]~I) concentration and on fl cell response to IV glucose, tolbutamide or glucagon in man. Each of the 53 subjects tested was studied on two separate occasions: i) in the basal state; ii) after an experimental decrease or increase in plasma FFA levels induced, respectively, by administration of nicotinic acid or the combination of a fat meal and heparin. The lowering of plasma FFA resulted in a small but significant fall in basal insulin concentration and in a 30% decrease in II~I response whatever the insulinotropic agent used. On the other hand, experimental elevation of plasma FFA enhanced pancreatic response to glucose (-~ 178%) and tolbutamide (n a 58%), but did not alter significantly the Ii~I respons~ to glucagon. Both the increase and the decrease in FFA concentration resulted in a reduction in the rate of glucose assimilation. --These results provide arguments for a role of plasma FFA in the control of insulin secretion and of insulin sensitivity in l~an.
Introduction
In addition to glucose, various other circulating substrates, such as aminoacids [1] and ketone bodies [2--4] , are known to stimulate insulin (II~I) secretion in vivo. Free fatty acids (FFA) are also capable of stimulating insulin release in some species. This effect has been shown in rive in dogs [5--8] and in vitro in rats [9] . In man, however, it has been observed that experimental elevations of plasma FFA concentration do not significantly increase basal Ii~I levels [10--11 ]. This does not necessarily indicate that human fi cells are insensitive to changes in concentration of this substrate. Indeed, Schaleh and Kipnis [I0] and Balasse and Ooms [lI] have shown that the insulin response to glucose is enhanced when FFA concentrations are elevated as the result of the combined administration of a fat meaI and heparin.
Owing to the obvious physiological importance of such a phenomenon, we have attempted in the present work to extend these earlier findings. Therefore we have tested whether experimental elevations or reductions in plasma FFA levels in man can modify the IgI response to various insulinotropic agents, namely glucose, tolbutamide and glucagon.
Material and Methods
The studies were performed on 53 ambulatory subjects of both sexes, aged 15--60 years (mean 33 years), after an overnight fast. * Work partiMly carried out under contract of the Fends de la l~echerehe Scientifique Mgdieale (n ~ 20193) and under contract of the Ministate de la Politique Seientifique within the framework of the Association EuratomUniversity of Brussels --University of Pisa.
In a first group of 26 obese subjects (body weight averaging 144% (122--183) of ideal weight), we studied the effect of an experimental decrease in FFA concentration on IRI response to 3 different insulinotropic substances i.e. glucose (25 g; 13 subjects), tolbutamide (1 g; 6 subjects) or glucagon (0.25 mg; 7 subjects), all agents being injected IV in 1 rain. Each subject was submitted to a given test of pancreatic stimulation on 2 separate days: orL one day, the test was performed in the basal state (control test); on tile other day, repeated IV injections of an antilipolytie agent (nicotinic acid, 100 mg every 15 min) were started 2 h before the test and. continued until the end of the experiment.
In a second group of 27 subjects (body weight averaging 114~ (82--148) of ideal weight) we tested the effect of an elevation of plasma FFA levels on fi cell secretion. The Ii~I response to IV glucose (12 subjects), tolbutamide (7 subjects) or glucagon (8 subjects) was measured both in the basal state and after administration of a fat meal and heparin. In this case, 250 ml of milk cream (containing 100 g of triglyeerides) was given orally 4 h before the test and followed by the IV injection of heparin 2 h (40 mg), 1 h (20 mg) and immediately before (20 rag) the injection of the insulinotropie agent.
During the various tests, plasma concentrations of glucose, FFA and IgI were determined on venous blood samples obtained at intervals as shown in Figs. 1-3 .
The time interval between 2 tests performed in the same individual varied between 1 and 7 days (mean 3 days) and subjects were instructed not to change their usual diet during this period. Iu 43 subjects, the control test was performed first whereas it was performed second in the 10 remaining subjects distributed in both groups. The order of sequence of the tests was without apparent inflnenee on the results.
Plasma glucose was determined by the method of tIoffmann [12] adapted to the Teehnicon Autoanalyser. In the subjects submitted to an IV glucose test, "K" value was determined according to Conard [13] . Plasma FFA were estimated according to Trout et al. [14] . In studies where FFA were elevated with a fat meal and heparin, i~ vitro lipolysis after sampling was prevented as described elsewhere (11). Plasma IgI was assayed according to Morgan and Lazarow [15] , using human insulin as standards. 
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<~ "E 100. * values being significantly different (p < 0.001) frona initial concentration from an average initial value of 0.78 ~moles/ml, FFA concentration attained 0.40 ~moles/ml after 60 min and 0.32 ~moles/ml after 120 min of nicotinic acid treatment, this fall being highly significant. Glycaemia remained unchanged whereas IRI levels decreased significantly, averaging 15.5 ~U/ml in the basal state and 10 FU/ml 120 min after starting the injections of nicotinic acid.
On the other hand, the administration of heparin to 20 subjects given a fat meal 2 h earlier significantly increased FFA concentration, which averaged, respectively, 0.80 ~moles/ml, 1.18 ~moles/ml and 1.03 ~moles/ml before, 60 min after and 120 min after starting heparin treatment. This rise had no effect on glyeaemia nor on IRI concentration.
II. Effects of changes in t'FA concentration on IRI response to glucose, tolbutamide or glucagon
Figs. 2 and 3 represent the average concentrations of glucose, IRI and FFA measured during the 3 different tests of pancreatic stimulation performed in the control state and after administration of nicotinic acid or of a fat meal plus heparin. Tables 1 and 2 provide 75  78  41  132  --74  92  49  49  53  67  66  73  43  37  63  55  55  58  52  77  85  95  100  80  70  71  59  61  117  69  63  70  68  51  69  64  66  5  7  8  10  9 11 10 <.001 <.01 <.0i <.01 <.02 <.02 <.02
Results are expressed as percent of corresponding values obtained during a control test in the same subject (for details in methods of calculation, see section "Results").
after injection of the insulinotropie agent). "K" values obtained from the IV glucose tests are also presented in Tables 1 and 2 and expressed as percent of control values. Table 1 ). The administration of nicotinic acid resulted in a decrease in FFA concentration which was already apparent after 30 rain and which persisted until the end of the tests (Fig. 2) . Average FFA levels in studies with nicotinic acid amounted to 51--64% of values observed in the control studies (Table 1) . This fall in FFA concentration was accompanied by a blunted pancreatic response to secretory agents. After nicotinic acid, IRI response to glucose, tolbutamide or glueagon, represented respectively 68 • 8% (SEM), 69 ~ 9% and 66 • 10% of control responses (Table 1) whereas glycaemic curves were minimally influenced (Fig. 2) . In studies with IV glucose, the "K" value averaged 1.67 % per min in the control experiments and was reduced by 30% (p<0.01) after nicotinic acid (Table 1) . Table 1 shows that there are important individual variations in the effects of nicotinic acid on IRI response to the stimulatory agents. Furthermore, there is no correlation between the fall in FFA concentration and the inhibition of pancreatic response nor is there a correlation between the latter and the deterioration of the "K" value. (Fig. 3 and Table 2 ). The administration of a fat meal did not significantly altered by the elevated FFA levels. For the IV glucose test, the "K" value averaged 1.63 ~=0.2% (SEM) per rain in the basal state and decreased by 11% after the fat meal and heparin, this fall being not statistically significant (Table 2) .
a) Effect of nicotinic acid on insulin secretion (_Fig. 2 and

b) Effect of the administration of a fat meal and heparin on insulin secretion
When all individual resut~s of this study are considered, a positive correlation is found (r=0.59; p<0.001) between changes in FFA concentrations (whether increased or decreased) and corresponding modifications in II~I response (Fig. 4) , whatever the insulinotropie agent used. change the plasma FFA concentration. After heparin, there was a sharp rise in FFA levels which peaked at about 1.2 ~moles/m130 to 60 rain after the first heparin injection. Subsequently, despite an additional injection of this drug, there was a slow decrease in FFA levels, further accentuated by the administration of the insulinotropic agents. On an average, FFA levels observed during the studies performed after the fat meal and heparin amounted to 140--192% of values obtained under control conditions (Table 2 ). These elevated levels of FFA were accompanied by a significantly increased insulin response to glucose and tolbutamide, representing respectively 278:E79% (SEM) and 158 4-17% of control response. However, there is no correlation between elevations of FFA and degree of enhancement of insulin secretion. The insulin response to glucagon was not significantly enhanced after the fat meal and heparin, despite a major increase in FFA levels. Glycaemic curves after IV glucose, tolbutamide or glucagon were minimally
Discussion
I. Effects of changes in FFA levels on basal concentration of glucose and IRI.
The absence of significant modification of basal glucose and IRI concentrations after a fat meal and heparin has been documented in other studies [10, 11] . In our experiments, the lowering of FFA levels by nicotinic acid was also without effect on glycaemia, but resulted in a small, progressive decrease in IRI concentration which was statistically significant 2 h after the onset of the nicotinic acid injections. Since this drug seems to be devoid of any direct inhibitory effect on fl cell secretion [16, 17] , it is possible that the observed fall in IRI concentration might be related to the reduction in FFA levels.
Opposite results were described by Miettinen et al. [18] who observed an increase in basal IRI concentration after nicotinic acid, but their observations were Diabetologia limited to the initial 30 min after nicotinic acid infusion and thus cannot be compared with ours.
II. Effects of changes in FFA concentrations on IRI response to glucose, tolbutamide and glucagon
Our results indicate that an increase in FFA levels following administration of a fat meal and hep arin results in an enhancement of IRI response to glucose, tolbutamide or glucagon, whereas the decrease in FFA level observed after nicotinic acid inhibits the insulin response to these agents. It should be mentioned, however, that the increase in pancreatic response to glueagon after a fat meal and heparin was not statistically significant. This might be due to the small number of patients tested. Among the 53 patients included in the whole study, only 7 had an "unexpected" response and there is a highly significant positive correlation between variations in FFA levels and o~ 300 1 58  117  t14  226  194  99  245  72  111  112  124  150  169  198  68  536  102  142  114  102  162  100  135  209  76  173  95  96  123  100  827  257  95  777  139  100  232  173  89  278  140  158  192  114  14  10  79  16  17  17 9 <.001 <.05 <.05 <.05 <.02 <.001 <.05
Results are expressed as percent of corresponding values obtained during a control test in the same subject (for details in methods of calculation, see section "l~e-suits"). changes in Ii~I response. However, as this is not the case in individual subgroups, the causative relationship between changes in FFA and corresponding changes in IRI might be questioned. The fact that the fat meal --heparin regimen on one hand and nicotinic acid on the other hand might influence pancreatic reactivity independently of the changes in FFA concentration they induce, should be taken into consideration. Indeed, the fat meal per se, which does not increase FFA levels, could enhance islet eel/response, for instance through secretion of gastro-intestinal hormones. The observations of Schalch and Kipnis [10] in man and of Szabo and l~ahter [19] in dogs do not substantiate this possibility. Pelkonen et al. [20] have noticed an increase in IRI response to IV glucose after a fat meal alone but the difference was statistically significant only at the 5th min of the test. A direct inhibitory effect of nicotinic acid on insulin secretion also seems improbable, according to in vitro data already mentioned [16, 17] . It is therefore reasonable to assume that the effects of the fat meal --heparin regimen or of nicotinic acid are due to concomitant changes in FFA concentration. The absence of correla-tion between FFA changes and IRI response in the individual subgroups might be explained if intracellular (fi cell) rather than plasma FFA concentrations were the critical factor in regulating insulin release. Indeed, it has been shown by Sehonfeld and Kipnis that, at least in rat muscle, these two concentrations are not rapidly equilibrated [21, 22] .
Several other reports have demonstrated that experimental increases in plasma FFA concentration only to glucose but also to other insulinotropic agents such as tolbutamide and glucagon. Since the insulinotropic effect of these two substances is known to be modulated by the availability and further metabolism of glucose in the fi cell [28, 17] , it is reasonable to hypothesize, in agreement with Montague et al. [29] , that FFA may influence the secretory process by inhibiting glyeolysis in islet tissue in much the same way as they do in muscle. [10--11] , by IV infusion of a fat emulsion [23, 24] , or by intraduodenal infusion of oetanoic acid [25] enhance the insulin response to glucose. Our data confirm these observations and indicate that this potentiating effect of FFA on insulin release also applies when tolbutamide and possibly ghieagon are used as stimulatory agents. The effects of nicotinic acid on IRI response to glucose have been studied by several authors with conflicting results: Miettinen et al. [18] observed no change in IRI response to IV glucose given 30 min after 200 mg of nicotinic acid, while Stowers et al. [26] , Briber et al. [27] and G6mez et al. [24] noticed a blunted pancreatic response to oral glucose given 2 h after the start of an infusion of nicotinic acid or of a related compound. Since in our studies, the inhibitory effect was also observed after 2 h of nicotinic acid treatment, it seems probable that the negative results published by Miettinen et al. should be ascribed to the fact that exposure to nicotinic acid was of much shorter duration. Our experiments also indicate that reduced FFA levels inhibit pancreatic response not
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III. Effects of changes in FFA concentration on glucose "K" value
On average, the glucose "K" value decreased after the fat meal plus heparin, but individual responses were variable and the changes observed are not statistically significant. As pointed out in a previous work from this laboratory [11], the greater the control "K" value, the greater the fall observed after a fat meal and heparin. This trend was confirmed in the present series: the average "K" value was 1.63% per rain for the whole group, 1.12 (0.9--1.5) % per rain for the patients who did not respond to the rise in FFA levels by a fall in "K" value, and 2.0 (1.2--2.8) % per rain in those who did respond.
Several workers, using various experimental protocols, also came to the conclusion that elevated FFA levels tend to decrease glucose assimilation. Schalcll and Kipnis observed a fall in "K" value in 10 out of 12 subjects given a fat meal and heparin and the percent fall was positively correlated to the percent increase in FFA concentration [10] . We did not observe such a correlation. A deterioration of oral glucose tolerance was observed by G6mez et al. [24] during the infusion of a triglyceride emulsion in man, while Balasse has shown that the administration of a fat emulsion and heparin reduces the rate of uptake and of oxidation of infused glucose in insulinized dogs [30] . In contrast, Pelkonen et al. [20] observed no significant effect of a fat meal and heparin on "K" value in man, but their study was limited to 5 cases only.
The fact that, in the present experiments, the enhancement in IRI release after the glucose load was not accompanied by an increase in its removal rate constant suggests that increased FFA concentration induced insulin resistance. This confirms our earlier results obtained with exogenous insulin [11] .
Nicotinic acid produced a significant decrease in "K" value averaging 30%, thus confirming the results published by Miettinen et al. [18] . These data are not in accord with the "glucose fatty acid cycle" theory [31], according to which a fall in FFA availability should result in a stimulation of glucose utilization at least by muscle. Other studies, using 14C-ghicose in vivo have shown that nicotinic acid increases the rate of glucose uptake and oxidation in dogs [32] and in rats [33] . Recent work from our laboratory indicates that this is also the case in starved and overnight-fasted humans, despite the fact that nicotinic acid produces a slight decrease in basal insulhl concentration [34] . The possible causes of the discrepancy between the effect of nicotinic acid on glucose utilization, whether it is measured by use of a glucose load or by use of tracer glucose, have been discussed by Miettinen et al. [18] . These authors have suggested that the decreased "K" value might be caused by an impairment in the assimilation of glucose by the liver through some action of nicotonic acid not related to antilipolysis. Although this explanation cannot be ruled out, our data suggest another possibility. Indeed, the reduction in "K" value after nicotinic acid could be accounted for by the inhibition of IRI response to glucose which masks the stimulatory effect of reduced FFA levels on glucose utilization. On the other hand, when the rate of glucose utilization is measured under normoglycaemic conditions with use of a tracer, nicotinic acid induces only a minor fall in basal IRI levels which does not interfere with the operation of the "glucose fatty acid cycle".
In conclusion, the main purpose of this work was to provide arguments suggesting that FFA levels exert a regulatory effect on IRI secretion in man in response to a variety of stimuli. It should be kept in mind, however, that these arguments are based on studies in which changes in FFA levels have been induced by unphysiological means. The possible relationship between FFA and pancreatic response might well have important pathophysiological implications. In many situations where hyperinsulinism is found, as in obesity or acromegaly, there is also an exaggerated high level of plasma FFA. Our data suggest that the latter might be one causative factor of the hyperinsulinism. As high levels of FFA are also capable of inducing insulin resistance, this substrate might be involved in the development of the hormonal syndrome associating hyperinsulinism and insulin resistance [35] , which is believed to be of primary importance in the genesis of various diabetic states.
